- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 307/58 - Un atome d'oxygène, p. ex. buténolide
Détention brevets de la classe C07D 307/58
Brevets de cette classe: 143
Historique des publications depuis 10 ans
|
1
|
4
|
3
|
8
|
2
|
14
|
4
|
8
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Nissan Chemical Industries, Ltd. | 1695 |
16 |
| BASF SE | 21109 |
5 |
| Ottawa Hospital Research Institute | 109 |
5 |
| Zhengzhou University | 142 |
4 |
| Boehringer Ingelheim International GmbH | 4596 |
3 |
| Syngenta Participations AG | 1672 |
3 |
| Henkel AG & Co. KGaA | 10643 |
3 |
| IHI Corporation | 3472 |
3 |
| The Regents of the University of California | 20315 |
2 |
| DSM IP Assets B.V. | 5490 |
2 |
| Korea Research Institute of Chemical Technology | 1421 |
2 |
| Nippon Shokubai Co., Ltd. | 1509 |
2 |
| The Regents of the University of Colorado, a body corporate | 2737 |
2 |
| University of Ottawa | 220 |
2 |
| Zhejiang University | 3286 |
2 |
| Institute of Medicinal Plant Development | 4 |
2 |
| Ottawa Hospital Research Institute and University of Ottawa | 2 |
2 |
| The Procter & Gamble Company | 22040 |
1 |
| Conopco, Inc. | 4943 |
1 |
| Mars, Incorporated | 2876 |
1 |
| Autres propriétaires | 80 |